ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation

被引:555
作者
Yang, Jer-Yen [1 ,2 ]
Zong, Cong S. [1 ]
Xia, Weiya [1 ]
Yamaguchi, Hirohito [1 ]
Ding, Qingqing [1 ]
Xie, Xiaoming [1 ]
Lang, Jing-Yu [1 ]
Lai, Chien-Chen [3 ]
Chang, Chun-Ju [1 ]
Huang, Wei-Chien [1 ]
Huang, Hsin [1 ,4 ]
Kuo, Hsu-Ping [1 ,2 ]
Lee, Dung-Fang [1 ,2 ]
Li, Long-Yuan [3 ,5 ]
Lien, Huang-Chun [6 ]
Cheng, Xiaoyun [1 ,2 ]
Chang, King-Jen [7 ,8 ]
Hsiao, Chwan-Deng [9 ]
Tsai, Fuu-Jen [3 ]
Tsai, Chang-Hai [3 ,5 ]
Sahin, Aysegul A. [10 ]
Muller, William J. [11 ,12 ]
Mills, Gordon B. [13 ]
Yu, Dihua [1 ,2 ]
Hortobagyi, Gabriel N. [14 ]
Hung, Mien-Chie [1 ,2 ,3 ,5 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA
[2] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA
[3] China Med Univ Hosp, Taichung 404, Taiwan
[4] Univ Calif Davis, Dept Internal Med, Div Infect Dis, Sacramento, CA 95817 USA
[5] Asian Univ, Taichung 413, Taiwan
[6] Natl Taiwan Univ, Dept Pathol, Taipei 106, Taiwan
[7] Natl Taiwan Univ, Coll Med, Dept Surg, Taipei 106, Taiwan
[8] Natl Taiwan Univ, Angiogenesis Res Ctr, Taipei 106, Taiwan
[9] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan
[10] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
[11] McGill Univ, Dept Med, Montreal, PQ H3A 1A1, Canada
[12] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A1, Canada
[13] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA
[14] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA
关键词
D O I
10.1038/ncb1676
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The RAS-ERK pathway is known to play a pivotal role in differentiation, proliferation and tumour progression. Here, we show that ERK downregulates Forkhead box O 3a (FOXO3a) by directly interacting with and phosphorylating FOXO3a at Ser 294, Ser 344 and Ser 425, which consequently promotes cell proliferation and tumorigenesis. The ERK-phosphorylated FOXO3a degrades via an MDM2-mediated ubiquitin-proteasome pathway. However, the non-phosphorylated FOXO3a mutant is resistant to the interaction and degradation by murine double minute 2 (MDM2), thereby resulting in a strong inhibition of cell proliferation and tumorigenicity. Taken together, our study elucidates a novel pathway in cell growth and tumorigenesis through negative regulation of FOXO3a by RAS-ERK and MDM2.
引用
收藏
页码:138 / U22
页数:17
相关论文
共 41 条
[1]   Mitogen-activated protein kinases, Erk and p38, phosphorylate and regulate Foxo1 [J].
Asada, Sachie ;
Daitoku, Hiroaki ;
Matsuzaki, Hitomi ;
Saito, Tomoko ;
Sudo, Tatsuhiko ;
Mukai, Hidehito ;
Iwashita, Shintaro ;
Kako, Koichiro ;
Kishi, Tsutomu ;
Kasuya, Yoshitoshi ;
Fukamizu, Akiyoshi .
CELLULAR SIGNALLING, 2007, 19 (03) :519-527
[2]   MDM2 is a central node in the p53 pathway: 12 years and counting [J].
Bond, GL ;
Hu, WW ;
Levine, AJ .
CURRENT CANCER DRUG TARGETS, 2005, 5 (01) :3-8
[3]   Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor [J].
Brunet, A ;
Bonni, A ;
Zigmond, MJ ;
Lin, MZ ;
Juo, P ;
Hu, LS ;
Anderson, MJ ;
Arden, KC ;
Blenis, J ;
Greenberg, ME .
CELL, 1999, 96 (06) :857-868
[4]   Cell cycle and death control: long live Forkheads [J].
Burgering, BMT ;
Kops, GJPL .
TRENDS IN BIOCHEMICAL SCIENCES, 2002, 27 (07) :352-360
[5]   The tumor suppression activity of E1A in HER-2/neu-overexpressing breast cancer [J].
Chang, JY ;
Xia, WY ;
Shao, RP ;
Sorgi, F ;
Hortobagyi, GN ;
Huang, L ;
Hung, MC .
ONCOGENE, 1997, 14 (05) :561-568
[6]   Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27KIP1 [J].
Dijkers, PF ;
Medema, RH ;
Pals, C ;
Banerji, L ;
Thomas, NSB ;
Lam, EWF ;
Burgering, BMT ;
Raaijmakers, JAM ;
Lammers, JWJ ;
Koenderman, L ;
Coffer, PJ .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (24) :9138-9148
[7]  
Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009
[8]   Activating FOX03a, NF-κB and p53 by targeting IKKs -: An effective multi-faceted targeting of the tumor-cell phenotype? [J].
Finnberg, N ;
El-Deiry, WS .
CANCER BIOLOGY & THERAPY, 2004, 3 (07) :614-616
[9]   Oncogenic Ras in tumour progression and metastasis [J].
Giehl, K .
BIOLOGICAL CHEMISTRY, 2005, 386 (03) :193-205
[10]   FOXO transcription factors at the interface between longevity and tumor suppression [J].
Greer, EL ;
Brunet, A .
ONCOGENE, 2005, 24 (50) :7410-7425